Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecabet in Dry Eye Disease
NCT00667004Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Mar 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ecabet sodium in dry eye disease (DED), sponsored by Bausch + Lomb. Started Mar 2008; status: completed.
02
Drugs
ecabet sodium
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00667004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667004.